178 related articles for article (PubMed ID: 36552831)
1. Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG.
Vázquez-Blomquist D; Hardy-Sosa A; Baez SC; Besada V; Palomares S; Guirola O; Ramos Y; Wiśniewski JR; González LJ; Bello-Rivero I
Cells; 2022 Dec; 11(24):. PubMed ID: 36552831
[TBL] [Abstract][Full Text] [Related]
2. A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG.
Miranda J; Vázquez-Blomquist D; Bringas R; Fernandez-de-Cossio J; Palenzuela D; Novoa LI; Bello-Rivero I
BMC Cancer; 2023 Aug; 23(1):806. PubMed ID: 37644431
[TBL] [Abstract][Full Text] [Related]
3. A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status.
Vázquez-Blomquist D; Leenstra S; van der Kaaij M; Villarreal A; Bello-Rivero I
Mol Biol Rep; 2020 Jul; 47(7):5263-5271. PubMed ID: 32607953
[TBL] [Abstract][Full Text] [Related]
4. HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment.
Bello-Rivero I; Garcia-Vega Y; Duncan-Roberts Y; Vazquez-Blomquistc D; Santana-Milian H; Besada-Perez V; Rios-Cabrera M
Semin Oncol; 2018 Jan; 45(1-2):27-33. PubMed ID: 30318081
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation.
Tripathi PH; Akhtar J; Arora J; Saran RK; Mishra N; Polisetty RV; Sirdeshmukh R; Gautam P
BMC Cancer; 2022 Feb; 22(1):133. PubMed ID: 35109816
[TBL] [Abstract][Full Text] [Related]
6. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
7. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.
Yang I; Kremen TJ; Giovannone AJ; Paik E; Odesa SK; Prins RM; Liau LM
J Neurosurg; 2004 Feb; 100(2):310-9. PubMed ID: 15086239
[TBL] [Abstract][Full Text] [Related]
8. Principal component analysis on LC‑MS/MS and 2DE‑MALDI‑TOF in glioblastoma cell lines reveals that mitochondria act as organelle sensors of the metabolic state in glioblastoma.
Gómez-Caudillo L; Ortega-Lozano AJ; Martínez-Batallar ÁG; Rosas-Vargas H; Minauro-Sanmiguel F; Encarnación-Guevara S
Oncol Rep; 2020 Aug; 44(2):661-673. PubMed ID: 32468038
[TBL] [Abstract][Full Text] [Related]
9. Phosphoproteome Dynamics of Streptomyces rimosus during Submerged Growth and Antibiotic Production.
Šarić E; Quinn GA; Nalpas N; Paradžik T; Kazazić S; Filić Ž; Šemanjski M; Herron P; Hunter I; Maček B; Vujaklija D
mSystems; 2022 Oct; 7(5):e0019922. PubMed ID: 36094082
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
11. SILAC quantitative proteomics analysis of ivermectin-related proteomic profiling and molecular network alterations in human ovarian cancer cells.
Li N; Li J; Desiderio DM; Zhan X
J Mass Spectrom; 2021 Jan; 56(1):e4659. PubMed ID: 33047383
[TBL] [Abstract][Full Text] [Related]
12. Profiling modifications for glioblastoma proteome using ultra-tolerant database search: Are the peptide mass shifts biologically relevant or chemically induced?
Tarasova IA; Chumakov PM; Moshkovskii SA; Gorshkov MV
J Proteomics; 2019 Jan; 191():16-21. PubMed ID: 29777870
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.
Jain R; Kulkarni P; Dhali S; Rapole S; Srivastava S
J Proteomics; 2015 Jan; 113():127-42. PubMed ID: 25286751
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.
Polisetty RV; Gautam P; Sharma R; Harsha HC; Nair SC; Gupta MK; Uppin MS; Challa S; Puligopu AK; Ankathi P; Purohit AK; Chandak GR; Pandey A; Sirdeshmukh R
Mol Cell Proteomics; 2012 Jun; 11(6):M111.013565. PubMed ID: 22219345
[TBL] [Abstract][Full Text] [Related]
15. Label-free quantitative proteomic and phosphoproteomic analyses of renal biopsy tissues in membranous nephropathy.
Li S; Luo Z; Meng S; Qiu X; Zheng F; Dai W; Zhang X; Sui W; Yan Q; Tang D; Dai Y
Proteomics Clin Appl; 2022 Jan; 16(1):e2000069. PubMed ID: 34543527
[TBL] [Abstract][Full Text] [Related]
16. Identification of secreted proteins regulated by cAMP in glioblastoma cells using glycopeptide capture and label-free quantification.
Hill JJ; Moreno MJ; Lam JC; Haqqani AS; Kelly JF
Proteomics; 2009 Feb; 9(3):535-49. PubMed ID: 19137551
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.
Velázquez-Enríquez JM; Ramírez-Hernández AA; Navarro LMS; Reyes-Avendaño I; González-García K; Jiménez-Martínez C; Castro-Sánchez L; Sánchez-Chino XM; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563422
[TBL] [Abstract][Full Text] [Related]
18. Deep Profiling of Proteome and Phosphoproteome by Isobaric Labeling, Extensive Liquid Chromatography, and Mass Spectrometry.
Bai B; Tan H; Pagala VR; High AA; Ichhaporia VP; Hendershot L; Peng J
Methods Enzymol; 2017; 585():377-395. PubMed ID: 28109439
[TBL] [Abstract][Full Text] [Related]
19. Phospho-proteomic analysis of developmental reprogramming in the moss Physcomitrella patens.
Wang X; Zhou S; Chen L; Quatrano RS; He Y
J Proteomics; 2014 Aug; 108():284-94. PubMed ID: 24933006
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Proteomics Reveals Temporal Proteomic Changes in Signaling Pathways during BV2 Mouse Microglial Cell Activation.
Woo J; Han D; Wang JI; Park J; Kim H; Kim Y
J Proteome Res; 2017 Sep; 16(9):3419-3432. PubMed ID: 28777000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
